UPDATE : Friday, October 18, 2019
RIGHT Fund reveals 1st investment into public health projects in developing countries by Lee Han-soo 2019-07-17 14:03
'Biktarvy -- a pill a day to treat HIV' by Lee Han-soo 2019-07-17 10:09
Ono Pharma Korea names new CEO by Lee Han-soo 2019-07-16 11:24
Daewoong, Medytox differ in interpreting US trade agency’s order by Lee Han-soo 2019-07-15 17:44
Self-claimed Korea Otsuka employee causes stir on far-right website by Lee Han-soo 2019-07-15 15:57
China OKs Huonland's hyaluronic acid eye drop by Lee Han-soo 2019-07-15 13:57
Japanese pharma companies closely following 'Boycott Japan' campaign by Lee Han-soo 2019-07-12 17:07
Daewoong to co-promote Lundbeck Korea's Alzheimer's disease treatment by Lee Han-soo 2019-07-12 15:13
Regulator OKs Merck Korea's relapsing-remitting multiple sclerosis treatment by Lee Han-soo 2019-07-11 17:39
Humira permitted for nursing, pregnant patients by Kim Yun-mi 2019-07-11 16:41
SCM Life Science, MitoImmune Therapeutics to develop new treatment by Lee Han-soo 2019-07-11 16:40
Acute renal failure reported in ibandronate injections by Lee Hye-seon 2019-07-11 13:34
Yuyu holds 3rd annual compliance program workshop by Lee Han-soo 2019-07-11 12:09
Contera Pharma gets ₩3 billion funding from venture capital by Jeong Sae-im 2019-07-10 17:28
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute by Jeong Sae-im 2019-07-10 12:44
'Teva's Fremanezumab improves migraine-related disorders, quality of life' by Lee Han-soo 2019-07-09 16:57
ISU Abxis, Kyungpook National University to co-develop Alzheimer's disease treatment by Lee Han-soo 2019-07-09 16:06
Sanofi Aventis names new general manager for consumer healthcare by Lee Han-soo 2019-07-09 15:16
GSK's Alitoc becoming salvation treatment for chronic hand eczema patients by Lee Han-soo 2019-07-09 14:44
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance by Lee Hye-seon 2019-07-08 16:39
Back to Top